Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. - Wikidata - wikimedia - TriplyDB

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

http://www.wikidata.org/entity/Q35094863

about

Progress in treatment of ANCA-associated vasculitis Silica exposure and systemic vasculitis The Prevalence and Management of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)Experimentally-induced anti-myeloperoxidase vasculitis does not require properdin, MASP-2 or bone marrow-derived C5 Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis The immunopathology of ANCA-associated vasculitis Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011.Pauci-immune crescentic glomerulonephritis superimposed on diabetic glomerulosclerosis Clinical Predictors of Outcome in Patients with Anti-neutrophil Cytoplasmic Autoantibody-related Renal Vasculitis: Experiences from a Single-center.Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse.Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.Management of ANCA-associated vasculitis: Current trends and future prospects Efficacy of remission-induction regimens for ANCA-associated vasculitis.High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome Immunotherapy for autoimmune and inflammatory renal diseases.Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies.Clinical [corrected] and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre.Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study.ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.Urinary FSP1 is a biomarker of crescentic GN Development of comprehensive disease assessment in systemic vasculitis.Necrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series.Pro: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?Immunization in Patients with Rheumatic Diseases: A Practical Guide for General Practitioners.Outcome and treatment of elderly patients with ANCA-associated vasculitis.urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse.A CD8+ T cell transcription signature predicts prognosis in autoimmune disease.B Cells, Antibodies, and More.Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.

P2860

Q21195258-A970C337-D8B9-485F-B087-AD12781CF362 Q24817062-72938C23-6961-4EA6-BC06-33078C4D5683 Q26740453-6E9A21AD-F69D-427E-8152-CDFE3175BF04 Q26864089-C1477A6E-8A5F-4D72-86A8-DBCA9B7E3451 Q27025692-CD8A2B30-23F4-40BC-AC1E-64BA07DBB357 Q27468849-0C3BA42A-2680-4C2C-80FA-3BFCA60E4EC8 Q28389271-29C54CA2-8019-45BD-BF6C-D9919CB0571B Q28391531-6DAE3D5F-1208-4987-814F-965C9AD85B99 Q30764638-9636C273-7D7E-41DF-8FF7-5D81951D4F1F Q33338386-C36FE823-F541-4E9A-AFA6-4A401FFA13D7 Q33608983-6F223220-2E01-4DE2-9570-1025A5350B64 Q33684065-CA0C833A-32FF-4E18-BB5A-B5A757EB0DB8 Q33697927-2BEE0B99-ECDB-466E-BEBD-61D6E8ADF3FD Q33771970-98F0D433-32E0-47F7-8BA6-8D57920B02D3 Q33862188-74D9E3F8-9F89-4F57-AE71-B377F7779674 Q33947599-65645685-2F80-467A-96A1-658A19310D66 Q34037683-F87D1D1C-F14C-491D-8159-E8A5B7BD48B9 Q34500661-87D4E071-6EC6-4440-8896-B4845754E851 Q34708735-C546E4C4-2CE2-42D3-B487-AD624DF7FD41 Q34965751-70140627-9C6C-4D62-98E6-BE6640DFB831 Q35007874-24EF380F-B04B-4701-9041-4C8AD85CDA1D Q35144046-A4F0F21F-21AE-4C3B-8768-FB6A032629AF Q35212086-2C811EF1-4F38-4107-966B-3411B5734E50 Q35523066-9D705101-FFF4-4DFD-8D55-B9FB9E7CD7FF Q35673484-7C48778F-9088-4045-A741-C0C19ECEBF08 Q35678050-828C1A6F-463D-4773-832D-338C3DEAB11C Q35715722-5022C67D-3643-4B64-BDAA-54F8C570061F Q35759939-84DECFAE-8ACB-4A3E-A6F8-A527DDC08EC7 Q35767701-80CAB968-7BEA-45AC-894D-4CDBBE7111E1 Q35777619-A1D50C8F-38B6-40F8-BBD5-05EF4327039F Q35792458-CE56838D-A653-4384-BAE7-10CC9C275A8D Q35816989-782DAFE4-EB37-458D-8D0F-619C36D91980 Q35861689-FC94556B-AB5E-43A2-BE3F-08A3EFA86407 Q36104863-6D89721B-EBA3-4CC1-B90F-8A9B4826DDAD Q36223713-58287BAD-CD95-40CF-A261-DE7A28198D0D Q36417832-5FCC5EA7-406E-4344-948A-E3754493DA23 Q36432935-B6F5296D-059E-4BE5-AA83-2952428472C6 Q36583330-61EF4FA3-7D44-441E-8DCF-F8FE9426E556 Q36652819-31D1EBDF-C11F-45AF-8D03-4A64865EDAF8 Q36684589-779B51AB-A2A6-4DA7-B687-AEB709F69727

P2860

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

http://www.wikidata.org/entity/Q35094863

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

@ast

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

@en

type

label

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

@ast

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

@en

prefLabel

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

@ast

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

@en

P1433

Q35094863-1022F933-3B2E-4A80-AE68-6432D693E355

P1476

Q35094863-8CB9C6F3-18A2-486F-AD75-7508D68BBA02

P2093

Q35094863-0DB19622-52F1-4202-B5CC-FE08D841F31A

Q35094863-163A2D9A-E818-44F9-88C4-812F0DD47D17

Q35094863-1DE81AE3-B308-4B25-A7BB-30B340A6401F

Q35094863-4EA22542-3AA9-4F43-B45F-BF08E9DD9408

Q35094863-65713D02-6159-4D5B-AF09-99DFE7C175EE

Q35094863-BFAC3DA9-DE6C-4686-B8B2-6E63824EF392

Q35094863-CB34F3F6-241F-40C0-9839-116C0BB5795A

Q35094863-D7D4A338-D00F-41E8-9028-97343A1B34DE

Q35094863-DAA21BD5-CBB6-49CA-8D78-C56E78904036

Q35094863-F2F092ED-38E2-4DCF-B50A-04236BB37EAE

P304

Q35094863-3AD2D6BE-961E-419C-BCFF-5F2FEA35ABCC

P31

Q35094863-E1B6959D-88F9-4D52-A16E-89A4CC7A250E

P356

Q35094863-9B7F3ED4-F245-497E-BE51-08830556C65E

P433

Q35094863-4E8E6696-AA6E-4348-9672-D271F68DA0C7

P478

Q35094863-193B82A0-5614-4EB0-A364-9DA9C1CDC179

P577

Q35094863-FE025D0C-4F4D-4ADA-B1E0-F5941613916C

P698

Q35094863-E6B53804-EE4C-462B-A4A5-61744E48BC25

P356

S0272-6386(03)00025-8

P1433

American Journal of Kidney Diseases

P1476

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

@en

P2093

Aine Burns

http://www.w3.org/2001/XMLSchema#string

Anthony D Booth

http://www.w3.org/2001/XMLSchema#string

Charles D Pusey

http://www.w3.org/2001/XMLSchema#string

David R W Jayne

http://www.w3.org/2001/XMLSchema#string

Gill Gaskin

http://www.w3.org/2001/XMLSchema#string

Guy H Neild

http://www.w3.org/2001/XMLSchema#string

Martin Plaisance

http://www.w3.org/2001/XMLSchema#string

Mike K Almond

http://www.w3.org/2001/XMLSchema#string

Pan-Thames Renal Research Group

http://www.w3.org/2001/XMLSchema#string

Peter Ellis

http://www.w3.org/2001/XMLSchema#string

P304

776-784

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0272-6386(03)00025-8

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12666064

http://www.w3.org/2001/XMLSchema#string